Biomarkers in MS
There are no biomarkers for diagnosis, prognosis and response to therapy in MS. MRI imaging, visual evoked potentials, oligoclonal bands in the CSF add to the diagnosis of MS; however, clinical presentation and following disease course still remains the golden rule. Is it an achievable goal to identify biomarkers? How would one do that? Is EDSS a reliable measure to quantify disease burden and progression?